Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong.

BACKGROUND Previous studies identifying associations between influenza and acute cardiac events may have been confounded by climatic factors. Differing seasonal patterns of influenza activity in Hong Kong and England and Wales provide a natural experiment to examine associations with myocardial infarction (MI) independent of cold weather effects. METHODS Weekly clinical and laboratory influenza surveillance data, environmental temperature and humidity data, and counts of MI-associated hospitalizations and deaths were obtained for England and Wales and for Hong Kong for the period 1998-2008. We used Poisson regression models that included environmental and seasonal variables to investigate the relationship between influenza and MI. RESULTS There were ≥1.2 million MI-associated hospitalizations and 410,204 MI-associated deaths in England and Wales, with a marked peak in the winter season. In Hong Kong, the incidence of MI, on the basis of 65,108 hospitalizations and 18,780 deaths, had a large winter and smaller summer peak, mirroring patterns of influenza activity. There was strong evidence for a link between influenza and MI both in England and Wales, where 3.1%-3.4% of MI-associated deaths (P < .001) and 0.7%-1.2% of MI-associated hospitalizations (P < .001) were attributable to influenza, and in Hong Kong, where the corresponding figures were 3.9%-5.6% (P = .018) and 3.0%-3.3% (P = .002). CONCLUSIONS Influenza was associated with an increase in MI-associated deaths and hospitalizations in 2 contrasting settings.

[1]  J. Sung,et al.  Seasonal influenza activity in Hong Kong and its association with meteorological variations , 2009, Journal of medical virology.

[2]  T. Tumpey,et al.  Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice , 2006, Journal of Virology.

[3]  D. Bainton,et al.  Influenza and ischaemic heart disease--a possible trigger for acute myocardial infarction? , 1978, International journal of epidemiology.

[4]  Lin Yang,et al.  Influenza-Associated Hospitalization in a Subtropical City , 2006, PLoS medicine.

[5]  V. Zarubaev,et al.  Clinical Research , 2022 .

[6]  N. Verlander,et al.  Evaluation of syndromic surveillance based on National Health Service Direct derived data--England and Wales. , 2005, MMWR supplements.

[7]  Jianhui Zhu,et al.  Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.

[8]  N. Nagelkerke,et al.  Validation of Syndromic Surveillance for Respiratory Pathogen Activity , 2008, Emerging infectious diseases.

[9]  D. Fleming The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. , 2000, Communicable disease and public health.

[10]  Xilin Yang,et al.  Changes in prevalence of influenza vaccination and strength of association of factors predicting influenza vaccination over time--results of two population-based surveys. , 2007, Vaccine.

[11]  J. W. Smith,et al.  Excess deaths attributable to influenza in England and Wales: age at death and certified cause. , 1983, International journal of epidemiology.

[12]  A. Peters,et al.  Air Temperature and Inflammatory Responses in Myocardial Infarction Survivors , 2008, Epidemiology.

[13]  T. Meade,et al.  Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. , 2007, European heart journal.

[14]  T. van der Poll,et al.  Effects on Coagulation and Fibrinolysis Induced by Influenza in Mice With a Reduced Capacity to Generate Activated Protein C and a Deficiency in Plasminogen Activator Inhibitor Type 1 , 2006, Circulation research.

[15]  W. Pan,et al.  Temperature extremes and mortality from coronary heart disease and cerebral infarction in elderly Chinese , 1995, The Lancet.

[16]  A. Hedley,et al.  Influenza-associated mortality in Hong Kong. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  Benjamin J Cowling,et al.  Methods for monitoring influenza surveillance data. , 2006, International journal of epidemiology.

[18]  K. Bhaskaran,et al.  Short term effects of temperature on risk of myocardial infarction in England and Wales: time series regression analysis of the Myocardial Ischaemia National Audit Project (MINAP) registry , 2010, BMJ : British Medical Journal.

[19]  D. Fleming,et al.  Lessons from 40 years' surveillance of influenza in England and Wales , 2007, Epidemiology and Infection.

[20]  D. Fleming,et al.  Influenza and its relationship to circulatory disorders , 2004, Epidemiology and Infection.

[21]  A. Meijer,et al.  Epidemiological and virological assessment of influenza activity in Europe during the winter 2005-2006. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  Li-xin Jiang,et al.  Influenza Virus Infection and Risk of Acute Myocardial Infarction , 2008, Inflammation.

[23]  L. Held,et al.  Multivariate modelling of infectious disease surveillance data , 2008, Statistics in medicine.

[24]  Jeremy Ginsberg,et al.  Detecting influenza epidemics using search engine query data , 2009, Nature.

[25]  R. Hubbard,et al.  Risk of myocardial infarction and stroke after acute infection or vaccination. , 2004, The New England journal of medicine.

[26]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[27]  K. Hon,et al.  Incidence of common respiratory viral infections related to climate factors in hospitalized children in Hong Kong , 2009, Epidemiology and Infection.

[28]  Liam Smeeth,et al.  Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. , 2009, The Lancet. Infectious diseases.

[29]  S. Meri,et al.  Elevated infection parameters and infection symptoms predict an acute coronary event , 2008, Therapeutic advances in cardiovascular disease.

[30]  J. Kai,et al.  Presentation with influenza-like illness in general practice: implications for use of neuraminidase inhibitors. , 2000, Communicable disease and public health.